🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide SYNCHRONIZE Phase 3 — November 2025 Page 4

Survodutide SYNCHRONIZE Phase 3 — November 2025

ZaraB_AL Thu, Sep 12, 2024 at 4:18 AM 56 replies 2,243 viewsPage 4 of 12
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Sep 23, 2024 at 4:22 PM#16

Adding the clinical framing, because it changes how the question reads. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

I would rather be corrected than agreed with, if it comes to it.

Last edited: Sep 23, 2024 at 7:22 PM
9 7labquiet_amy, emily_PDX, Dr.SleepRoch and 6 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Sep 25, 2024 at 7:51 AM#17

Adding the numbers, since they settle part of this. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Sep 25, 2024 at 11:51 AM
10 8MariaRD, AussieAnna, BethLabQueen and 7 others
Reply Quote Save Share Report
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Sep 26, 2024 at 11:19 PM#18

A narrower follow-up, since the general answer is now clear:

Was that from a primary source or from a summary of one?

11 9GraceAZ_72, carl_compliance, DanielChem_CHI and 8 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
SkepticalSean
Member
98
345
Jan 2025
Maine
Sep 28, 2024 at 2:46 PM#19
anders_CPH said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

12 10tammy_FL, Dr.LipidDallas, alex_tucson and 9 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Sep 30, 2024 at 6:12 AM#20

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again.

34 7PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 31 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register